Company Overview - AbCellera was founded in 2012, originating from an academic lab at the University of British Columbia, focusing on technology that integrates microfluidics and single-cell analysis to discover therapeutic antibodies [3]. Technology Development - Over the past decade, AbCellera has concentrated on enhancing its technology platform, achieving complete GMP manufacturing capabilities in Vancouver [4].